Roof rats (Rattus rattus) live mainly in human habitats. Heavy use of rodenticides, 18 such as warfarin, has led to the development of drug resistance, making pest control 19 difficult. There have been many reports regarding mutations of vitamin K epoxide 20 reductase (VKOR), the target enzyme of warfarin, in resistant rats. However, it has been 21 suggested there are other mechanisms of warfarin resistance. To confirm these 22 possibilities, closed colonies of warfarin-susceptible roof rats (S) and resistant rats from 23 Tokyo (R) were established, and the pharmacokinetics/pharmacodynamics of warfarin 24 in rats from both colonies were investigated. R rats had low levels of warfarin in serum 25 p. 2 and high clearance activity. These rats can rapidly metabolize warfarin by hydroxylation.
p. 6 vet) was obtained from Kyoritsu Seiyaku (Tokyo, Japan). Isoflurane was obtained from 126 DS Pharma Animal Health (Osaka, Japan). 127 128 2.3 Warfarin administration and blood collection 129 Before administration, rats were anesthetized with medetomidine (0.375 mg kg -1 ), 130 midazolam (2.0 mg kg -1 ), and butorphanol (2.5 mg kg -1 ) (i.p.), and anesthesia was 131 maintained with 2.5% -3% isoflurane. Under anesthesia, the cervical cutis was incised 132 to visualize the jugular vein. Then, 10 mg kg -1 of warfarin dissolved in distilled water 133 was administered orally (n = 4, male) or i.v. (n = 4, male) via the jugular vein. Rats were 134 placed on a disposable heating pad to maintain their body temperature. 135 Samples of approximately blood (100 μl) were taken from the jugular vein through the 136 sternocleidomastoid muscle at 5 minutes, and 1, 2, 4, 6, 10, 26, 33, and 51 hours after 137 administration. Administration and blood collection were performed under 2.5% -3% 138 isoflurane anesthesia. Prothrombin time was measured at 5 minutes, and 6, 10, 26, 33, 139 and 51 hours with CoaguCheck XS (Roche Diagnostics, Basel, Switzerland). After 140 sampling at 51 hours, rats were euthanized with an overdose of isoflurane, and the liver, 141 kidneys, spleen, heart, lungs, testis, and brain were collected. 144 For urine and feces collection, warfarin (10 mg kg -1 ) was administered orally to 145 susceptible/resistant rats (male, n = 5). Rats were anesthetized briefly with isoflurane, 146 and warfarin (10 mg kg -1 ) was administered orally. The rats were then kept in metabolic 147 cages (Shinano Corporation, Tokyo, Japan), one per cage, for 48 hours with food and 148 water available ad libitum. Urine and feces were collected at 24 and 48 hours. are shown in Figure S1 , S2 and Table S2 , S3. shown in Table- S4. In contrast, there were no differences in levels of the five 289 metabolites and parent warfarin examined in the feces of S and R rats ( Figure S3 ). the liver and 10-hydroxywarfarin in the liver and kidney were also significantly higher 299 in S rats than R rats (shown in Figure S4 and Table S5 ). In this study, we analyzed the pharmacokinetics of warfarin in warfarin-resistant (R) 322 and warfarin-susceptible (S) male roof rats. R rats showed low AUC and high clearance 323 activity of warfarin after both p.o. and i.v. administration (Table 1 ). However, there was 324 no significant difference in BA between the two strains, which means absorption and 325 p. 14 first pass effect in liver was not different between two strains.
Urine and feces collection after oral warfarin administration

326
Although there was no difference in BA of warfarin, R rats seemed to have the ability 327 to metabolize warfarin rapidly. Pharmacokinetics of hydroxywarfarin of i.v.
328
administrations showed the basis of rapid excretion. The concentrations of 4'-, 6-, 7-, 329 and 8-OH warfarin at 1 hour after administration were significantly higher in R rats than 330 S rats although administration volume (C max ) of warfarin was larger in S rats (shown 331 Figure S2 , and Table S1 ). In addition, T max of 4'-, 6-and 7-OH warfarin of R 332 rats was significantly earlier than that of S rats. Thus, the metabolic ability of CYPs, 333 which catalyze warfarin hydroxylation, is higher in R rats than S rats. The tendency of 334 early T max was also observed in p.o. administration but no significantly difference 335 ( Figure S1 ).
336
Clinically, polymorphism of CYP2C9 is known to influence warfarin sensitivity in high clearance of warfarin in R rats seemed to due to high metabolic activity by CYPs. 346 Immunoblotting analysis revealed that the relatively high expression levels of CYP2B,
347
2C and 3A in R rats after warfarin administration (Figure 7) . These results suggest that 348 the high warfarin metabolic activity of R rats seems to be due to the high expression 349 level of these CYPs. Tokyo used in these experiments would have high induction of CYPs when exposed to 354 rodenticides.
355
There have been some reports that some 2nd generation rodenticides can induce CYPs. further studies to measure UGT activity in vitro are necessary.
393
Although even S rats excreted most of warfarin within 48 h after single administration,
394
S rats tended to accumulate warfarin compared to R rats ( Figure 6 This study showed the high metabolic activity of warfarin in warfarin-resistant (R) 402 roof rats (Rattus rattus) in vivo and high expression levels of several CYP subfamilies.
403
The R rats also had Vkorc1 mutation, and pharmacodynamic analysis showed that 404 warfarin had no effect on R rats, at least with a single administration ( Figure 2 ). These warfarin-susceptible (n = 7) and -resistant (n =7) males were measured. * means there is 601 significant difference between two strains (student's t test, p = 0.05 Table 2 . Mean (±standard error) pharmacokinetic parameters of hydroxywarfarin after 612 oral or intravascular administration at a dose of 10 mg/kg to susceptible (n = 4) and 613 resistant rats (n = 4). T max means the time when concentration reach maximum value 614 (C max ). AUC; area under curve of plasma-time profile of OH-warfarin. * means there is 615 significantly difference between both strains (student's t test, p = 0.05). Figure S3 . Excretion levels of warfarin and its metabolites in feces of susceptible rats (S, 627 n = 5) and resistant rats (R, n = 5). Rats were kept in metabolic cages after oral 628 administration of 10 mg kg -1 of warfarin for 48 h. Feces were collected at the time of 24 629 h and 48 h. 630 Figure S4 . Hydroxywarfarin concentration in liver and kidney at 51 h after the oral 631 administration of hydroxywarfarin. OH-warfarin concentrations in liver of susceptible 632 (n = 6) and resistant (n = 6) roof rats were measured. * means there is significantly 633 difference between both strains, S and R (student's t test, p = 0.05 shown in Table 6 ). 
